American Century Companies Inc Viking Therapeutics, Inc. Transaction History

American Century Companies Inc

$157 Billion
Q1 2025

A detailed history of American Century Companies Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 297,729 shares of VKTX stock, worth $8.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

297,729

Previous 301,582 1.28%

Holding current value

$8.34 Million

Previous $12.1 Million 40.75%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$24.15 - $42.89 $93,049 - $165,255	-3,853 Reduced 1.28%	297,729 $7.19 Million
Q4 2024 Feb 11, 2025	BUY	$38.28 - $78.03 $988,542 - $2.02 Million	25,824 Added 9.36%	301,582 $12.1 Million
Q3 2024 Nov 12, 2024	BUY	$49.84 - $70.47 $115,080 - $162,715	2,309 Added 0.84%	275,758 $17.5 Million
Q2 2024 Aug 07, 2024	SELL	$47.39 - $80.2 $26.5 Million - $44.8 Million	-558,683 Reduced 67.14%	273,449 $14.5 Million
Q1 2024 May 14, 2024	SELL	$17.4 - $94.5 $24.2 Million - $132 Million	-1,391,690 Reduced 62.58%	832,132 $68.2 Million
Q4 2023 Feb 13, 2024	BUY	$9.24 - $19.64 $20.5 Million - $43.7 Million	2,223,822 New	2,223,822 $41.4 Million
Q3 2023 Nov 13, 2023	BUY	$10.92 - $16.0 $8.98 Million - $13.2 Million	822,156 Added 59.57%	2,202,228 $24.4 Million
Q2 2023 Aug 14, 2023	BUY	$14.84 - $24.79 $20.1 Million - $33.6 Million	1,355,183 Added 5444.91%	1,380,072 $22.4 Million
Q1 2023 May 11, 2023	BUY	$8.08 - $17.33 $44,795 - $96,077	5,544 Added 28.66%	24,889 $414,000
Q4 2022 Feb 13, 2023	BUY	$2.72 - $9.4 $52,618 - $181,843	19,345 New	19,345 $181,000
Q1 2020 May 14, 2020	SELL	$3.45 - $7.95 $1.98 Million - $4.57 Million	-574,424 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$6.38 - $8.73 $1.66 Million - $2.28 Million	260,768 Added 83.14%	574,424 $4.61 Million
Q3 2019 Nov 13, 2019	BUY	$6.55 - $8.6 $123,912 - $162,694	18,918 Added 6.42%	313,656 $2.16 Million
Q2 2019 Aug 14, 2019	BUY	$7.67 - $10.63 $439,276 - $608,801	57,272 Added 24.12%	294,738 $2.45 Million
Q1 2019 May 14, 2019	SELL	$7.58 - $9.94 $81,485 - $106,855	-10,750 Reduced 4.33%	237,466 $0
Q4 2018 Feb 13, 2019	SELL	$7.16 - $16.21 $41,191 - $93,256	-5,753 Reduced 2.27%	248,216 $1.9 Million
Q3 2018 Nov 02, 2018	BUY	$9.7 - $19.65 $2.46 Million - $4.99 Million	253,969 New	253,969 $4.42 Million

Others Institutions Holding VKTX

# of Institutions

432

Shares Held

65.2M

Call Options Held

8.28M

Put Options Held

3.39M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $2.15B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Viking Therapeutics, Inc. Transaction History